People | February 17, 2026
Roche appoints Mark Dawson as new Head of Pharma Research and Early Development
Dawson joins Roche from the Peter MacCallum Cancer Centre, where he serves as Associate Director of Research
Dawson joins Roche from the Peter MacCallum Cancer Centre, where he serves as Associate Director of Research
The FDA’s Center for Biologics Evaluation and Research (CBER) cited Moderna’s choice of a licensed standard-dose flu vaccine as the comparator in its Phase 3 trial, saying it “does not reflect the best-available standard of care.”
BioAsia 2026 represents a decisive shift toward execution, scale, and global competitiveness, reflecting the rapid evolution of the life sciences ecosystem
The company reported profit before tax of Rs.67 crore, up sharply from Rs.21 crore in the same period last year
Launched in August 2025, GSK India’s Oncology business is rapidly gaining momentum
HCG clinicians contributing to one of the largest bodies of oncology research from India
Capital expenditure stood at Rs. 405 crore to date against a planned Rs. 700 crore for FY26
Pfizer’s anti-infectives portfolio includes both established therapies for moderate to severe infections and newer, clinically robust antimicrobial treatments
Glucon-D maintained its leadership position with a 59% MAT market share
The company maintained a competitive ARPOB while steadily improving occupancy, driven by higher patient volumes and efficient capacity utilization
Subscribe To Our Newsletter & Stay Updated
